Johnson & Johnson (NYSE:JNJ)
| 158.39 Delayed Data As of Dec 01 |  +3.73 / +2.41%Today’s Change | 144.95 Today|||52-Week Range 181.04 | -10.34% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $381.3B |
Company Description
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women's Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.Contact Information
Johnson & Johnson One Johnson & Johnson Plaza New Brunswick New Jersey 08933 |
Employees
Shareholders
| Mutual fund holders | 35.86% |
| Other institutional | 35.18% |
| Individual stakeholders | 0.25% |
Top Executives
| Joaquin Duato | Chairman & Chief Executive Officer |
| Joseph J. Wolk | Chief Financial Officer & Executive Vice President |
| Matthew Stuckley | Senior Finance Director |
| James D. Swanson | Global Chief Information Officer & Executive VP |
| Ahmet Tezel | Global Head-Research & Development |
